Osteopore Ltd Total Liabilities

Latest as of December 2025: AU$4.50 Million AUD ≈ $3.18 Million USD

Osteopore Ltd total liabilities. Based on the latest financial reports, Osteopore Ltd (OSX) has total liabilities worth AU$4.50 Million AUD (≈ $3.18 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Osteopore Ltd (OSX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Osteopore Ltd (2016–2025)

Total liabilities of Osteopore Ltd from 2016 to 2025. This chart illustrates how Osteopore Ltd's total liabilities have evolved over time, based on quarterly financial data.

Osteopore Ltd Competitors by Total Liabilities

The table below lists competitors of Osteopore Ltd ranked by their total liabilities.

Company Country Total Liabilities
GENERAL COPPER GOLD CORP.
F:7S50
Germany €619.10K
Margaret Lake Diamonds Inc
V:DIA
Canada CA$859.97K
Bonyf NV
PA:MLBON
France €1.25 Million
Future Supply Chain Solutions Limited
NSE:FSC
India Rs3.32 Billion
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB
USA $19.83 Million
CYCLIQ Group Ltd
AU:CYQ
Australia AU$1.74 Million
Mobius Investment Trust PLC
LSE:MMIT
UK GBX1.91 Million
VULTUS AB
F:V06
Germany €5.15 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Osteopore Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see OSX total assets.

Liquidity & Leverage Metrics

Osteopore Ltd Total Liabilities Ratios Explained

Osteopore Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.21 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.61 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.62 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Osteopore Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Osteopore Ltd (2016–2025)

The table below shows the annual total liabilities of Osteopore Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 AU$4.50 Million
≈ $3.18 Million
+59.11%
2024-12-31 AU$2.83 Million
≈ $2.00 Million
-2.82%
2023-12-31 AU$2.91 Million
≈ $2.06 Million
+92.30%
2022-12-31 AU$1.51 Million
≈ $1.07 Million
+138.97%
2021-12-31 AU$633.40K
≈ $448.17K
-49.39%
2020-12-31 AU$1.25 Million
≈ $885.58K
-5.01%
2019-12-31 AU$1.32 Million
≈ $932.29K
+12.72%
2018-12-31 AU$1.17 Million
≈ $827.07K
-46.50%
2017-12-31 AU$2.18 Million
≈ $1.55 Million
-1.37%
2016-12-31 AU$2.22 Million
≈ $1.57 Million
--

About Osteopore Ltd

AU:OSX Australia Medical Instruments & Supplies
Market Cap
$1.30 Million
AU$1.84 Million AUD
Market Cap Rank
#30458 Global
#1783 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.03
All Time High
AU$15.65
About

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its tech… Read more